Rivia raises €13M to bring agentic AI to clinical trials

The Next Web
Read full post
Rivia has secured €13 million in funding to develop agentic AI technologies aimed at enhancing clinical trial processes. The investment will support the company's efforts to integrate autonomous AI agents into healthcare research workflows.

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources
Healthcare5 min read

​Digital Finance Needs A New Kind Of Identity For AI-Driven Economies

Forbes

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News